Shopping Cart
- Remove All
- Your shopping cart is currently empty
Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $120 | 35 days | |
10 mg | $223 | 35 days |
Description | Ivermectin B1a monosaccharide is produced by selective hydrolysis of the terminal saccharide unit of ivermectin. It can inhibit nematode larval development, but does not cause paralytic activity. This compound has been used as a probe to detect some types of ivermectin resistance. |
Molecular Weight | 730.936 |
Formula | C41H62O11 |
Cas No. | 71837-27-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO: Soluble Methanol: Soluble DMF: Soluble Ethanol: Soluble |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.